Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Novartis Ireland Lt regarding Gilenya (fingolimod) – Updated recommendations to minimise the risk of drug-induced liver injury (DILI)
Important Safety Information - Gilenya (fingolimod)